BRCA1 and breast cancer: The prevalence of germline BRCA1/2 (gBRCA1/2) PVs/LPVs in BC was reported earlier in other Middle East and North Africa (MENA) countries; 12.9% in Saudi Arabia, 15.1% in Morocco, 15.5% in Lebanon and 13.9% in Jordan16–19 and in other studies15,20,21.